参考文献/References:
[1]Yang B,Li J,Li F,et al.Comprehensive analysis of age-related somatic mutation profiles in Chinese young lung adenocarcinoma patients[J].Cancer Med,2019,8(4):1350-1358.[2]Huang X,Le W,Chen Q,et al.Suppression of the innate cancer-killing activity in human granulocytes by stress reaction as a possible mechanism for affecting cancer development[J].Stress,2020,23(1):87-96.[3]Zhang Y,Zanos P,Jackson IL,et al.Psychological stress enhances tumor growth and diminishes radiation response in preclinical model of lung cancer[J].Radiother Oncol,2020,146:126-135.[4]骆小娟,陈辉,余丽梅.化学发光法检测非小细胞肺癌患者血清雌激素和血管内皮生长因子水平及其临床意义[J].临床合理用药杂志,2021,14(7):27-30.[5]Tang J,Wang Y,Luo Y,et al.Computational advances of tumor marker selection and sample classification in cancer proteomics[J].Comput Struct Biotechnol J,2020,18:2012-2025.[6]Xu H,Yang X,Xuan X,et al.STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway[J].Neoplasia,2021,23(6):607-623.[7]Du R,Shen W,Liu Y,et al.TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness[J].Signal Transduct Target Ther,2019,4:60.[8]Pi C,Xu CR,Zhang MF,et al.EGFR mutations in early-stage and advanced-stage lung adenocarcinoma: Analysis based on large-scale data from China[J].Thorac Cancer,2018,9(7):814-819.[9]李婉琳.基于中国人群肺腺癌常见突变的比较基因组学分析[D].南京:南京医科大学,2020.[10]韩乐,陈文娟,张一力.肺腺癌392例临床病理特征与骨转移相关性分析[J].陕西医学杂志,2020,49(12):1688-1690.[11]Bing Z,Xiaoye A,Yasheng A.P3.01-003 Study of the Relationship between EGFR Mutation Status and Bone Metastasis in Advanced Lung Adenocarcinoma[J].Journal of Thoracic Oncology,2017,12(11):S2201.[12]孙向飞,张晓炜,董济民.晚期非小细胞肺癌EGFR基因突变及其与患者临床特征的相关性[J].海南医学,2020,31(12):1500-1503.[13]张炜,郭万华,李爱梅,等.中晚期非小细胞肺癌骨转移与EGFR基因突变相关分析[J].东南大学学报(医学版),2018,37(4):711-715.[14]Gao J,Li HR,Jin C,et al.Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer[J].Clin Transl Oncol,2019,21(10):1287-1301.[15]Liu S,Cao H,Chen D,et al.LXR ligands induce apoptosis of EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt-NF-κB activation[J].Oncol Lett,2018,15(5):7168-7174.[16]王晓丽,刘晓莹,谢靖红.多b值DWI序列ADC值联合肿瘤标志物检测对肝脏良恶性肿瘤诊断中的临床价值[J].中国CT和MRI杂志,2020,18(1):101-104.[17]曹仲年,郑容,魏正茂,等.肿瘤标志物和肺门淋巴结与肺腺癌全身骨显像骨转移的关系[J].肿瘤防治研究,2019,46(2):149-152.[18]Ayan AK,Erdemci B,Orsal E,et al.Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis?[J].Rev Esp Med Nucl Imagen Mol,2016,35(2):102-106.[19]杜恩赐.SPECT全身骨显像联合肿瘤标志物水平检测在非小细胞肺癌骨转移中的应用[J].河南医学研究,2021,30(14):2654-2656.[20]Lequaglie C,Marino P,Maioli C,et al.Cyfra 21-1 - a new tumor-marker for lung-cancer[J].Oncol Rep,1995,2(1):119-122.[21]王海玉,魏晨晨,王礼学,等.血清CEA、CYFRA21-1联合ALP在非小细胞肺癌骨转移诊断中的应用[J].医学研究杂志,2021,50(6):36-40.[22]Tang J,Ge QM,Huang R,et al.Clinical Significance of CYFRA21-1, AFP, CA-153, CEA, and CA-199 in the Diagnosis of Lung Cancer Ocular Metastasis in Hypertension Population[J].Front Cardiovasc Med,2021,8:670594.[23]胡一明,徐旭燕,张艺.CK5/6、CK7以及CYFRA21-1联合检测在肺腺癌骨转移的诊断研究[J].国际呼吸杂志,2019,39(14):1057-1061.[24]Zhou Y,Chen WZ,Peng AF,et al.Neuron-specific enolase, histopathological types, and age as risk factors for bone metastases in lung cancer[J].Tumour Biol,2017,39(7):1010428317714194.[25]Guo X,Ma W,Wu H,et al.Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China[J].BMC Cancer,2021,21(1):613.[26]周平,程丰飞.MRI联合多层螺旋CT在脊柱转移瘤患者中的辅助诊断价值及与肿瘤标志物的相关性研究[J].医学影像学杂志,2021,31(7):1228-1231,1246.[27]Sha R,Badhulika S.Recent advancements in fabrication of nanomaterial based biosensors for diagnosis of ovarian cancer: a comprehensive review[J].Mikrochim Acta,2020,187(3):181.[28]Zhou Y,Yu QF,Peng AF,et al.The risk factors of bone metastases in patients with lung cancer[J].Sci Rep,2017,7(1):8970.[29]Zang S,He Q,Bao Q,et al.Establishment and validation of a novel survival prediction scoring algorithm for patients with non-small-cell lung cancer spinal metastasis[J].Int J Clin Oncol,2019,24(9):1049-1060.[30]Jiang X,Bao Y,Liu H,et al.VPS34 stimulation of p62 phosphorylation for cancer progression[J].Oncogene,2017,36(50):6850-6862.[31]Li D,He C,Ye F,et al.p62 Overexpression Promotes Bone Metastasis of Lung Adenocarcinoma out of LC3-Dependent Autophagy[J].Front Oncol,2021,11:609548.[32]Sultana MA,Cluning C,Kwong WS,et al.The SQSTM1/p62 UBA domain regulates Ajuba localisation, degradation and NF-κB signalling function[J].PLoS One,2021,16(11):e0259556.[33]Rydlander L,Ziegler E,Bergman T,et al.Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18[J].Eur J Biochem,1996,241(2):309-314.[34]Ren X,Zhang Y,Lyu Y,et al.Lactate dehydrogenase and serum tumor markers for predicting metastatic status in geriatric patients with lung adenocarcinoma[J].Cancer Biomark,2019,26(2):139-150.[35]Shen H,Li Y,Liao Y,et al.Lower blood calcium associates with unfavorable prognosis and predicts for bone metastasis in NSCLC[J].PLoS One,2012,7(3):e34264.[36]Wu XT,Zhou JW,Pan LC,Ge T.Clinical features and prognostic factors in patients with bone metastases from non-small cell lung cancer[J].J Int Med Res,2020,48(5):300060520925644.[37]胡兵,孟倩.PTH、Ca、P在肿瘤骨转移判断中的变化分析[J].标记免疫分析与临床,2021,28(10):1741-1745.[38]Weissensteiner J,Babusikova E.The value of human epididymis protein 4 (HE4) as a serum tumor marker for accurate bone metastases finding by whole-body bone scintigraphy in lung cancer patients[J].Neoplasma,2019,66(6):1024-1030.[39]蒋怡芳,范晓杰,耿楠,等.血清细胞角蛋白5/6和细胞角蛋白7及甲状腺转录因子-1诊断肺癌骨转移的价值[J].中华实用诊断与治疗杂志,2021,35(8):838-840.[40]Wang Z,Yang MQ,Lei L,et al.Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis[J].Cancer Manag Res,2019,11:7485-7497.[41]Durán Botía F,Fernández-Ace?觡ero MJ,Ruiz Adelantado I,et al.Bone metastasis of papillary thyroid carcinoma simulating a pulmonary origin. Unusual immunohistochemistry leading to misdiagnosis[J].Rev Esp Patol,2020,53(4):264-267.[42]夏前林,付亚文,滕小艳,等.肺癌骨转移患者血清NFKBIA和LETMD1的表达及诊断价值[J].中华肿瘤防治杂志,2021,28(18):1392-1397.[43]Ni J,Zhang X,Li J,et al.Correction: Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts[J].Cell Death Dis,2021,12(12):1131.[44]Jia J,Huang B,Zhuang Z,et al.Circulating tumor DNA as prognostic markers for late stage NSCLC with bone metastasis[J].Int J Biol Markers,2018,33(2):222-230.[45]Mao CG,Jiang SS,Wang XY,et al.BCAR1 plays critical roles in the formation and immunoevasion of invasive circulating tumor cells in lung adenocarcinoma[J].Int J Biol Sci,2021,17(10):2461-2475.
相似文献/References:
[1]廖 祺,黄 一,徐 雪.前列腺癌骨转移的疼痛管理[J].医学信息,2018,31(06):51.[doi:10.3969/j.issn.1006-1959.2018.06.017]
LIAO Qi,HUANG Yi,XU Xue.Pain Management of Bone Metastasis in Prostate Cancer[J].Journal of Medical Information,2018,31(23):51.[doi:10.3969/j.issn.1006-1959.2018.06.017]
[2]刘治利,葛明建.肺部磨玻璃结节的CT特征与治疗策略进展[J].医学信息,2018,31(11):49.[doi:10.3969/j.issn.1006-1959.2018.11.016]
LIU Zhi-li,GE Ming-jian.Advances in CT Features and Treatment Strategies of Pulmonary Ground-glass Nodule[J].Journal of Medical Information,2018,31(23):49.[doi:10.3969/j.issn.1006-1959.2018.11.016]
[3]彭玉龙,张 露,陈荣辉,等.吉西他滨与培美曲塞联合卡铂治疗晚期肺腺癌的临床观察[J].医学信息,2018,31(11):124.[doi:10.3969/j.issn.1006-1959.2018.11.039]
PENG Yu-long,ZHANG Lu,CHEN Rong-hui,et al.Clinical Observation of Gemcitabine and Pemetrexed Combined with Carboplatin in Treatment of Advanced Lung Adenocarcinoma[J].Journal of Medical Information,2018,31(23):124.[doi:10.3969/j.issn.1006-1959.2018.11.039]
[4]李 科.骨形态发生蛋白4与乳腺癌骨转移的相关性研究[J].医学信息,2018,31(13):17.[doi:10.3969/j.issn.1006-1959.2018.13.005]
LI Ke.Relationship between Bone Morphogenetic Protein 4 and Bone Metastasis in Breast Cancer[J].Journal of Medical Information,2018,31(23):17.[doi:10.3969/j.issn.1006-1959.2018.13.005]
[5]缪继东.盐酸吗啡缓释片联合低剂量阿米替林治疗中重度癌性骨痛的疗效观察[J].医学信息,2018,31(21):147.[doi:10.3969/j.issn.1006-1959.2018.21.042]
MIAO Ji-dong.Effects of Morphine Hydrochloride Sustained-release Tablets Combined with Low Dose Amitriptyline in the Treatment of Moderate and Severe Cancer Bone Pain[J].Journal of Medical Information,2018,31(23):147.[doi:10.3969/j.issn.1006-1959.2018.21.042]
[6]刘贤丰,李子俊.恩度联合培美曲塞与顺铂治疗晚期肺腺癌的临床效果观察[J].医学信息,2019,32(03):148.[doi:10.3969/j.issn.1006-1959.2019.03.048]
LIU Xian-feng,LI Zi-jun.Clinical Observation of Endo Combined with Pemetrexed and Cisplatin in the Treatment of Advanced Lung Adenocarcinoma[J].Journal of Medical Information,2019,32(23):148.[doi:10.3969/j.issn.1006-1959.2019.03.048]
[7]葛丽艳,王 琦,朱 宏,等.基于数据挖掘分析GPR35表达对肺腺癌预后的影响[J].医学信息,2018,31(23):86.[doi:10.3969/j.issn.1006-1959.2018.23.024]
GE Li-yan,WANG Qi,ZHU Hong,et al.The Effect of GPR35 Expression on Prognosis of Lung Adenocarcinoma was Analyzed Based on Data Mining[J].Journal of Medical Information,2018,31(23):86.[doi:10.3969/j.issn.1006-1959.2018.23.024]
[8]卜易莹,韩东兴,刘邦令,等.血清miR-145表达与乳腺癌患者的相关性分析[J].医学信息,2019,32(07):5.[doi:10.3969/j.issn.1006-1959.2019.07.002]
BU Yi-ying,HAN Dong-xing,LIU Bang-ling,et al.Correlation Analysis between Serum miR-145 Expression and Breast Cancer Patients[J].Journal of Medical Information,2019,32(23):5.[doi:10.3969/j.issn.1006-1959.2019.07.002]
[9]黄琪峰,郑琳琳,张 菁.生物信息学分析筛选肺腺癌靶基因及评估预后的价值[J].医学信息,2019,32(22):62.[doi:10.3969/j.issn.1006-1959.2019.22.020]
HUANG Qi-feng,ZHENG Lin-lin,ZHANG Jing.Bioinformatics Analysis of Screening Lung Adenocarcinoma Target Genes and Evaluating Prognostic Value[J].Journal of Medical Information,2019,32(23):62.[doi:10.3969/j.issn.1006-1959.2019.22.020]
[10]唐怀慧,王忠帅,邵茜茜,等.基于TCGA数据库肺腺癌RNAs构建ceRNA网络的综合分析[J].医学信息,2020,33(07):90.[doi:10.3969/j.issn.1006-1959.2020.07.025]
TANG Huai-hui,WANG Zhong-shuai,SHAO Qian-qian,et al.Comprehensive Analysis of Constructing ceRNA Network Based on TCGA Database of Lung Adenocarcinoma RNAs[J].Journal of Medical Information,2020,33(23):90.[doi:10.3969/j.issn.1006-1959.2020.07.025]